Integrated CRISPR screening and drug profiling identifies combination opportunities for EGFR, ALK, and BRAF/MEK inhibitors
综合 CRISPR 筛选和药物分析可确定 EGFR、ALK 和 BRAF/MEK 抑制剂的联合用药机会
期刊:Cell Reports
影响因子:7.5
doi:10.1016/j.celrep.2023.112297
Ralph Tiedt, Frederick J King, Christelle Stamm, Matthew J Niederst, Scott Delach, Sabine Zumstein-Mecker, Jodi Meltzer, Iain J Mulford, Emma Labrot, Barbara Schacher Engstler, Sabrina Baltschukat, Grainne Kerr, Javad Golji, Daniel Wyss, Christian Schnell, Edward Ainscow, Jeffrey A Engelman, William